Using similar methods as Mihai et al., Feng et al. identified a promotion function for the CaSR in metastatic prostate cancer; thus by pathological and statistical analysis, they found that compared to non-metastatic prostate cancer tissue, metastatic cancer tissue specifically expressed a higher level of the CaSR [61]. The gene discussed is CASR; the disease is Familial prostate cancer.